Trial intelligence / Profile preview

Sevoflurane study in mitral valve cardiac surgery

NL-OMON20447Not yet recruiting

Start
Nov 2009
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of sevoflurane in mitral valve disease (2 arms), sponsored by none. Primary endpoints: Acute inflammatory response factors, Factors involved in ischemia-reperfusion injury pathophysiology and 1 more. Planned start Nov 2009; status: not yet recruiting.

02

Drugs

sevoflurane
03

Conditions

mitral valve disease

Beyond the preview

Go deeper on NL-OMON20447.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON20447.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call